Hepatitis B Foundation
In research, Hepatitis B Foundation stands highest in Medicine (#12,637 of 17,978 worldwide) and Health Sciences (#15,000 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences — Medicine is 4.3× its share of world research.
- World rank, all time
- #22,920 of 42,892
- Rank in United States
- #4,935 of 8,685
- Research works
- 266 ▼ 7% vs 2013–17
- Citations
- 9.4k 35.5 per fractional work
- Top-10% rate
- 20.9% record average 16.5%
- Open access
- 57% world 28%
What is Hepatitis B Foundation known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #12,637 of 17,978 | 21.9% | 197 | |
| Health SciencesDomain | #15,000 of 20,462 | 21.9% | 206 |
Each strip is that field’s whole ranked pool, with the notch where Hepatitis B Foundation sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Hepatitis B Foundation specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.3× the share of its output that it takes of world research.
- MedicineField · 34.3 works4.3×
- Health SciencesDomain · 35.8 works3.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Immunology and Microbiology 1.4×
- Health Professions 1.3×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Psychology 0.5×
- Social Sciences 0.4×
- Biochemistry, Genetics and Molecular Biology 0.4×
- Business, Management and Accounting 0.2×
- Arts and Humanities 0.1×
- Neuroscience 0.1×
- Environmental Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.0×
- Engineering 0.0×
Who are the top researchers at Hepatitis B Foundation?
Ranked on the composite score, Chari Cohen lead among researchers whose main affiliation is Hepatitis B Foundation.
- 1 Chari Cohen United States · #1,085,973 worldwide 15 citations · 15 works
Which keywords describe research at Hepatitis B Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immune Response, Liver Disease, Antiviral Therapy, Hepatocellular Carcinoma, Epidemiology, Treatment, Chronic Hepatitis B and Hepatitis B Virus.
- drug use
- HIV
- Public Health
- Chronic Infection
- Genetic Diversity
- NASH
- Metabolic Syndrome
- Hepatic Steatosis
- Hepatitis C Virus
- Hepatitis B Virus
- Treatment
- Hepatocellular Carcinoma
- Liver Disease
- Immune Response
- Antiviral Therapy
- Epidemiology
- Chronic Hepatitis B
- Genetic Variation
- Ribavirin
- Insulin Resistance
- NAFLD
- Vaccine
- Zoonotic Transmission
- Hepatitis E Virus
- Diagnosis
- Pathogenesis
- Health Education
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Immune Response20▲ 86×6 topics
- Liver Disease20▲ 516×3 topics
- Antiviral Therapy20▲ 481×2 topics
- Hepatocellular Carcinoma15▲ 176×3 topics
- Epidemiology14▲ 8.8×17 topics
- Treatment11▲ 21×3 topics
- Chronic Hepatitis B10▲ 699×1 topic
- Hepatitis B Virus10▲ 699×1 topic
- Genetic Variation10▲ 110×2 topics
- Hepatitis C Virus10▲ 685×1 topic
- Ribavirin10▲ 685×1 topic
- Hepatic Steatosis5▲ 76×2 topics
- Insulin Resistance5▲ 26×3 topics
- Metabolic Syndrome5▲ 15×4 topics
- NAFLD5▲ 94×1 topic
- NASH5▲ 94×1 topic
- Vaccine3▲ 19×7 topics
- Genetic Diversity2▲ 14×2 topics
- Zoonotic Transmission2▲ 85×2 topics
- Chronic Infection2▲ 444×1 topic
- Hepatitis E Virus2▲ 444×1 topic
- Public Health2▲ 2.5×6 topics
- Diagnosis1▲ 3.2×3 topics
- HIV1▲ 31×1 topic
- Pathogenesis1▲ 5.0×9 topics
- drug use1▲ 89×1 topic
- Health Education1▲ 5.5×2 topics
Which research topics does Hepatitis B Foundation publish most on?
By volume in 2022–2025: Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment and Hepatitis Viruses Studies and Epidemiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hepatitis B Virus Studies Epidemiology 10 works
- 2 Hepatitis C virus research Hepatology 10 works
- 3 Liver Disease Diagnosis and Treatment Epidemiology 5 works
- 4 Hepatitis Viruses Studies and Epidemiology Hepatology 2 works
- 5 HIV, Drug Use, Sexual Risk Epidemiology 1 works
- 6 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 1 works
- 7 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 1 works
- 8 HIV/AIDS Research and Interventions Infectious Diseases 1 works
- 9 Vaccine Coverage and Hesitancy Health 1 works
- 10 Psychology of Development and Education Developmental and Educational Psychology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hepatitis B Foundation's research output changed?
Output in 2018–2022 was 7% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Doylestown
- BioClinica (United States)
- Doylestown Hospital
- Delaware Valley College
- Advanced Neural Dynamics (United States)
- Baruch S. Blumberg Institute
- Fox Chase Chemical Diversity Center
- Bucks County Intermediate Unit
- ALS Biopharma (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.